Read + Share
Bergman DR, Wang Y, Trujillo E, Fernald AA, et al. Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and
presents therapeutic possibilities in an agent-based model. Front Immunol 2024;15:1358019.
PMID: 38515743
|
 |
|
Bergman DR, Wang Y, Trujillo E, Fernald AA, et al. Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and
presents therapeutic possibilities in an agent-based model. Front Immunol 2024;15:1358019.
PMID: 38515743
|
|
|
|